Smith Hunter C's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 19, 2026
- Accession no.
- 0001104659-26-017729
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 0 derivative transactions. Open-market sales total $805.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Hunter CCIK 0001636385 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | SSaleDisposed | −1,200 | $99.42 | −$119,304 | 117,266 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −200 | $100.52 | −$20,104 | 117,066 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −900 | $101.70 | −$91,530 | 116,166 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −1,069 | $103.00 | −$110,107 | 115,097 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −200 | $103.84 | −$20,768 | 114,897 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −1,308 | $100.27 | −$131,153.16 | 113,589 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −1,692 | $100.92 | −$170,756.64 | 111,897 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −800 | $102.10 | −$81,680 | 111,097 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −585 | $103.28 | −$60,418.8 | 110,512 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.